Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome

Affiliations

• ¹ Department of Hematopathology, University Hospital Schleswig-Holstein, Kiel, Germany.
• ² Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
• ³ Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
• ⁴ HTG Molecular Diagnostics Inc, Tucson, AZ, 85706, USA.
• ⁵ Department of Pathology, University of Würzburg, Würzburg, Germany.
• ⁶ Department of Pathology, University Hospital Frankfurt, Frankfurt, Germany.
• ⁷ Department of Pathology, University Hospital Ulm, Ulm, Germany.
• ⁸ Institut für Hämatopathologie, Kiel, Germany.
• ⁹ Hämatopathologie Lübeck, Lübeck, Germany.
• ¹⁰ Department of Pathology, University Hospital Schleswig-Holstein, Lübeck, Germany.
• ¹¹ Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
• ¹² Department of Hematopathology, University Hospital Schleswig-Holstein, Kiel, Germany. wklapper@path.uni-kiel.de.